详细信息
糖尿病肾病患者发生心血管并发症的研究现状
Research status of cardiovascular complications in diabetic nephropathy patients
文献类型:期刊文献
中文题名:糖尿病肾病患者发生心血管并发症的研究现状
英文题名:Research status of cardiovascular complications in diabetic nephropathy patients
作者:马红梅[1];武振亚[1];王丽娟[1];刘胜男[1];王飞茹[2];汤惠惠[1];杨文[2];王紫琼[2];王金羊[3]
第一作者:马红梅
机构:[1]甘肃中医药大学第一临床医学院,甘肃兰州730000;[2]兰州大学第一临床医学院,甘肃兰州730000;[3]甘肃省人民医院内分泌科,甘肃兰州730000
第一机构:甘肃中医药大学临床医学院
年份:2025
卷号:41
期号:7
起止页码:1038
中文期刊名:中国临床药理学杂志
外文期刊名:The Chinese Journal of Clinical Pharmacology
收录:;北大核心:【北大核心2023】;
基金:国家自然科学基金资助项目(81760147,81860275,82360163);甘肃省自然科学基金资助项目(21JR1RA013,24JRRA589)。
语种:中文
中文关键词:糖尿病;慢性肾疾病;心血管疾病;炎症机制;治疗进展
外文关键词:diabetes mellitus;chronic kidney disease;cardiovascular disease;inflammatory mechanism;treatment progress
摘要:糖尿病(DM)患者出现并发症后,会加重病情,导致体内多组织器官受到持续性影响,进而出现诸多的并发症。慢性肾疾病(CKD)和心血管疾病(CVD)是2型糖尿病(T2DM)的主要并发症,增加了心血管和全因死亡的风险。目前,延缓CKD进展和CVD发展的治疗药物包括血管紧张素转换酶抑制药、血管紧张素Ⅱ受体阻滞药、钠-葡萄糖共转运蛋白2抑制药、胰高血糖素样肽-1受体激动药、盐皮质激素受体拮抗药等。尽管使用上述药物治疗可以延缓糖尿病患者大血管和微血管并发症的进展,但T2DM合并CKD患者仍存在CVD的高风险。本综述深入探讨T2DM患者CKD与CVD之间的关系,以期为临床治疗提供依据。
After the occurrence of complications in diabetes mellitus(DM)patients,the condition will be aggravated,resulting in sustained effects on multiple tissues and organs in the body,thus many complications.Chronic kidney disease(CKD)and cardiovascular disease(CVD)are major complications of type 2 diabetes mellitus(T2DM),increasing the risk of cardiovascular and all-cause death.Current therapeutic agents that delay the progression of CKD and CVD include angiotensin-converting enzyme inhibitors,angiotensinⅡreceptor blockers,sodium-glucose cotransporter 2 inhibitors,glucagon-like peptide-1 receptor agonists and salocorticoid receptor antagonists,etc.Although the use of these drugs can delay the progression of macrovascular and microvascular complications in patients with diabetes,T2DM patients with CKD are still at high risk of CVD.This review explores the relationship between CKD and CVD in T2DM patients,in order to provide evidence for clinical treatment.
参考文献:
正在载入数据...